Cardiff Oncology Inc. buy BiotechBee
Start price
29.04.24
/
50%
€4.28
Target price
31.07.26
€5.00
Performance (%)
-24.44%
Price
13.05.24
€3.23
Summary
This prediction is currently active. The price of Cardiff Oncology Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -24.44%. This prediction currently runs until 31.07.26. The prediction end date can be changed by BiotechBee at any time. BiotechBee has 50% into this predictionPerformance without dividends (%)
Name | 1w |
---|---|
Cardiff Oncology Inc. | 8.027% |
iShares Core DAX® | 1.851% |
iShares Nasdaq 100 | 1.573% |
iShares Nikkei 225® | -0.412% |
iShares S&P 500 | 1.128% |
According to BiotechBee what are the pros and cons of Cardiff Oncology Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Trovagene diskutieren
Buy mit Kursziel 5,0